Welcome to our new website. We have rebranded from Atnahs to Pharmanovia — read more

19th March 2020

COVID-19: Atnahs Continues Operations

Basildon (UK), 19 March 2020  – On 11 March 2020 the World Health Organization (WHO) declared...

More information
19th March 2020

Atnahs Acquires Rights to Rocaltrol®, An Established Brand in Women’s Health

Basildon (UK) / Basle (Switzerland), 19 March 2020 – Atnahs (“Atnahs”), a Triton Fund V portfolio company,...

More information
6th February 2020

Atnahs Buys Takeda Out of License Agreement for Bonviva® in Asia

Basildon (UK), 6 February 2020 – Atnahs has bought Takeda out of a license agreement for...

More information
27th January 2020

Atnahs Acquires Rights to Established Hypertension Medicines

Basildon / Cambridge (UK), 27 January 2020 – Atnahs, a Triton Fund V portfolio company, has signed...

More information
8th August 2019

Triton Completes Acquisition of a Majority Stake in Atnahs

Frankfurt (Germany), Basildon (United Kingdom), August 8, 2019 – Funds advised by Triton have successfully completed...

More information
14th December 2018

Atnahs Acquires Famvir®

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of Famvir® from...

More information
1st December 2018

Atnahs Opens New Branch in the United Arab Emirates (UAE)

Dubai, UAE. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new...

More information
28th February 2018

Atnahs Acquires Remaining Stake in Pharmanovia A/S in Denmark

Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of the remaining share capital...

More information
1st November 2017

Atnahs Launches Traxidot® (Tranexamic Acid) in the Netherlands

Basildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the launch of Traxidot® (Tranexamic...

More information